CARLSBAD, Calif., Oct. 29 /PRNewswire/ -- SkinMedica, Inc.'s 45 sales consultants from the Aesthetics Division converged on San Diego recently to take part in a spectacular sales meeting at the historic Hotel Del Coronado. The sales consultants were joined by an additional 40 employees from sales, marketing, research and development, customer service, human resources, finance and operations. CEO Mary Fisher kicked off the meeting with an inspirational speech on her vision of the business.

The theme of the meeting was "Hot New Products," reflecting both the division's largest and most innovative new product to date and the presence of the Hotel Del Coronado in the 1959 classic movie, Some Like it Hot starring Marilyn Monroe, Tony Curtis and Jack Lemmon. Over four days, the sales consultants attended sessions on upcoming new products, ingredient education, international business and a presentation by local prominent board-certified dermatologist, Dr. Deborah Atkin. The sales consultants were also treated to an elegant awards dinner honoring their accomplishments.

The highlight of the meeting was the unveiling of SkinMedica's newest product; TNS Essential Serum(TM), a revolutionary dual chamber, anti-aging serum. TNS Essential Serum is the first product to combine TNS Recovery Complex(R) and new APS Corrective Complex(TM). Clinical studies show these two formulas work in synergy to transform and regenerate skin for a more youthful, glowing appearance.

"TNS Essential Serum is a true innovation in skin rejuvenation," says Ted Schwarz, Vice President of Sales and Marketing, Aesthetics. "TNS Essential Serum, developed through extensive research, is a unique, physiological complex containing hundreds of growth factors, cytokines, antioxidants and peptides. I believe TNS Essential Serum is the most advanced topical skin rejuvenation therapy available today."

TNS Essential Serum is clinically proven to reduce fine and coarse wrinkles, skin roughness and uneven skin tone, improve skin radiance and elasticity and prevent UV induced skin damage.

SkinMedica, Inc. is an aesthetic and pharmaceutical company focused on developing, acquiring and commercializing products that improve the appearance of skin and treat dermatologic conditions and diseases.

About SkinMedica

SkinMedica, Inc. is a specialty pharmaceutical company focused on developing, acquiring and commercializing products that treat dermatologic conditions and diseases and improve the appearance of skin. We market and sell, primarily to dermatologists, both prescription pharmaceutical products and physician-dispensed, non-prescription skin care products. SkinMedica's pharmaceutical products include Desonate(R) (desonide) Gel 0.05% for the treatment of mild to moderate atopic dermatitis; VANIQA(R) (eflornithine hydrochloride) Cream, 13.9%, the only FDA-approved prescription product for the treatment of unwanted facial hair in women; NeoBenz(R) Micro, which contains a patented gradual-release formulation of benzoyl peroxide, treats acne; and EpiQuin(R) Micro (4% Hydroquinone) for the treatment of melasma and postinflammatory hyperpigmentation. The company's full line of aesthetic products-which began with TNS Recovery Complex(R) as the inspiration for its comprehensive line-are designed to enhance skin appearance, reduce signs of aging and provide other skin care benefits. SkinMedica is based in Carlsbad, California. For more information, visit: http://www.skinmedica.com.

Desonate(R), EpiQuin(R) Micro, NeoBenz(R) Micro, NouriCel-MD(R), SkinMedica(R), TNS Recovery Complex(R) and VANIQA(R) are trademarks of SkinMedica, Inc.

     CONTACT INFORMATION:
     Lisa O'Connor
     SkinMedica, Inc.
     (760) 448-3707
     loconnor@skinmedica.com
     http://www.skinmedica.com

SOURCE SkinMedica, Inc.